Dean Michael C, Cherian Nathan J, Etges Ana Paula Beck da Silva, LaPorte Zachary L, Dowley Kieran S, Torabian Kaveh A, Dean Ryan E, Martin Scott D
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
Mayo Clinic Alix School of Medicine, Rochester, Minnesota, U.S.A.
Arthrosc Sports Med Rehabil. 2025 Jan 3;7(2):101073. doi: 10.1016/j.asmr.2024.101073. eCollection 2025 Apr.
To characterize variation in the value of hip arthroscopy for femoroacetabular impingement and explore associations between value and patient-specific demographic characteristics, comorbidities, preoperative patient-reported outcome measures (PROMs), and intraoperative variables.
We included all patients aged 18 years or older who underwent primary arthroscopic acetabular labral repair or debridement between 2015 and 2020 with minimum 2-year follow-up. The exclusion criteria were hip dysplasia, advanced hip osteoarthritis (TÖnnis grade >1), or unreconcilable documenting errors. Value was calculated by dividing 2-year postoperative International Hip Outcome Tool 33 scores by time-driven activity-based costs. To protect the confidentiality of internal hospital cost data, the study average for value was normalized to 100. Multivariable linear mixed-effects models were used to identify factors underlying variation in value.
This study included 161 patients. There were 76 women (47.2%) and 85 men, with a mean age of 36.0 years (standard deviation [SD], 10.9 years) and mean body mass index (BMI) of 25.8 (SD, 4.3). Most patients were white (92.5%), were not Hispanic (93.8%), and were commercially insured (92.5%). Preoperatively, 57.1% of hips were classified as Tönnis grade 1 (57.1%) whereas the remainder were grade 0. The normalized value of hip arthroscopy ranged from 25.4 to 216.4 (mean ± SD, 100 ± 38.4), with a 3.0-fold variation between patients in the 10th and 90th percentiles. Higher value was significantly associated with Tönnis grade 0 (12.2-point increase, = .025), no prior contralateral hip arthroscopy (17.3-point increase, = .039), higher preoperative PROMs (0.52-point increase per 1-unit increase, < .001), and no bone marrow aspirate concentrate or microfracture (33.8-point increase, < .001). Value was also significantly associated with osteoplasty type and labral treatment technique ( < .05 for both). In contrast, operative year, age, sex, BMI, race, ethnicity, Outerbridge grade, and American Society of Anesthesiologists score were not independently associated with value. A model incorporating these factors as fixed effects and the surgery center as a random effect explained 42.3% of the observed variation in value. Sensitivity analyses revealed that value drivers may vary slightly across PROMs.
This study revealed wide variation in the value of hip arthroscopy that was most strongly explained by osteoplasty type, labral management technique, and preoperative PROMs. In contrast, patient demographic characteristics such as age, sex, and BMI contributed minimal independent variability.
Level IV, economic and decision analysis.
描述髋关节镜治疗股骨髋臼撞击症的价值变化,并探讨价值与患者特定人口统计学特征、合并症、术前患者报告结局指标(PROMs)以及术中变量之间的关联。
我们纳入了2015年至2020年间接受初次关节镜下髋臼盂唇修复或清创术且年龄在18岁及以上的所有患者,并进行了至少2年的随访。排除标准为髋关节发育不良、晚期髋关节骨关节炎(Tönnis分级>1)或无法调和的记录错误。通过将术后2年的国际髋关节结局工具33评分除以基于时间驱动活动的成本来计算价值。为保护医院内部成本数据的保密性,将研究的价值平均值标准化为100。使用多变量线性混合效应模型来识别价值变化的潜在因素。
本研究纳入了161例患者。其中女性76例(47.2%),男性85例,平均年龄36.0岁(标准差[SD],10.9岁),平均体重指数(BMI)为25.8(SD,4.3)。大多数患者为白人(92.5%),非西班牙裔(93.8%),且有商业保险(92.5%)。术前,57.1%的髋关节被分类为Tönnis 1级(57.1%),其余为0级。髋关节镜的标准化价值范围为25.4至216.4(平均值±SD,100±38.4),第10百分位数和第90百分位数的患者之间存在3.0倍的差异。较高的价值与Tönnis 0级显著相关(增加12.2分,P = 0.025),无既往对侧髋关节镜检查(增加17.3分,P = 0.039),术前PROMs较高(每增加1个单位增加0.52分,P < 0.001),以及无骨髓抽吸浓缩物或微骨折(增加33.8分,P < 0.001)。价值还与截骨术类型和盂唇治疗技术显著相关(两者P < 0.05)。相比之下,手术年份、年龄、性别、BMI、种族、民族、Outerbridge分级和美国麻醉医师协会评分与价值无独立关联。将这些因素作为固定效应并将手术中心作为随机效应纳入的模型解释了观察到的价值变化的42.3%。敏感性分析表明,价值驱动因素可能因PROMs而异。
本研究揭示了髋关节镜价值的广泛差异,其中截骨术类型、盂唇处理技术和术前PROMs对此解释最为有力。相比之下,年龄、性别和BMI等患者人口统计学特征对独立变异性的贡献最小。
IV级,经济和决策分析。